BRPI0917290A2 - composição imunológica - Google Patents

composição imunológica

Info

Publication number
BRPI0917290A2
BRPI0917290A2 BRPI0917290A BRPI0917290A BRPI0917290A2 BR PI0917290 A2 BRPI0917290 A2 BR PI0917290A2 BR PI0917290 A BRPI0917290 A BR PI0917290A BR PI0917290 A BRPI0917290 A BR PI0917290A BR PI0917290 A2 BRPI0917290 A2 BR PI0917290A2
Authority
BR
Brazil
Prior art keywords
immune composition
immune
composition
Prior art date
Application number
BRPI0917290A
Other languages
English (en)
Inventor
Philip Ralph Lehrbach
William John Cheshire
Zhixian Xin
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008904261A external-priority patent/AU2008904261A0/en
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of BRPI0917290A2 publication Critical patent/BRPI0917290A2/pt
Publication of BRPI0917290A8 publication Critical patent/BRPI0917290A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
BRPI0917290A 2008-08-19 2009-08-19 Composição imunológica BRPI0917290A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2008904261A AU2008904261A0 (en) 2008-08-19 Immunological Composition
US9209108P 2008-08-27 2008-08-27
PCT/US2009/054285 WO2010022135A1 (en) 2008-08-19 2009-08-19 Immunological composition

Publications (2)

Publication Number Publication Date
BRPI0917290A2 true BRPI0917290A2 (pt) 2015-11-10
BRPI0917290A8 BRPI0917290A8 (pt) 2016-11-01

Family

ID=41696586

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917290A BRPI0917290A8 (pt) 2008-08-19 2009-08-19 Composição imunológica

Country Status (16)

Country Link
US (1) US20100047279A1 (pt)
EP (1) EP2331126A1 (pt)
JP (1) JP2012500282A (pt)
KR (1) KR101320141B1 (pt)
CN (1) CN102186502B (pt)
AR (1) AR076437A1 (pt)
AU (1) AU2009282581B2 (pt)
BR (1) BRPI0917290A8 (pt)
CA (1) CA2734654C (pt)
CO (1) CO6341568A2 (pt)
MX (1) MX2011001910A (pt)
RU (1) RU2506094C2 (pt)
TW (1) TW201010719A (pt)
UA (1) UA101385C2 (pt)
WO (1) WO2010022135A1 (pt)
ZA (1) ZA201102082B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2485725A2 (en) * 2009-10-07 2012-08-15 Wyeth LLC Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
ES2617743T3 (es) * 2010-03-12 2017-06-19 Merial, Inc. Vacunas recombinantes del virus de la lengua azul y sus utilizaciones
WO2012154739A1 (en) * 2011-05-09 2012-11-15 Uwm Research Foundation, Inc. The use of cyclodextrins in diets, water or vaccine adjuvants to boost the immune system of fish
CN103083658B (zh) * 2011-10-27 2015-09-02 普莱柯生物工程股份有限公司 一种用于治疗或预防猪感染性疾病的疫苗佐剂组合物
MX2016004961A (es) 2013-10-17 2016-06-28 Zoetis Services Llc Procedimientos y composiciones para el tratamiento de infecciones por s. equi.
AU2015263877B2 (en) * 2014-05-23 2021-01-21 Desert King International Llc Combination, composition, and method of administering the combination or composition to animals
BR102021012953A2 (pt) * 2021-06-29 2023-01-10 Fabp Biotech Desenvolvimento Em Biotecnologia Ltda. Composição de vacina veterinária contra helmintos, método para tratamento e prevenção de infecção causada por helmintos e uso

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295749A1 (en) * 1987-06-15 1988-12-21 Duphar International Research B.V Sulpholipopolysaccharides as stimulators of the non-specific defence mechanism
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
CA2302522C (en) * 1997-08-29 2010-08-17 Antigenics Llc Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
PT1104306E (pt) * 1998-08-10 2006-05-31 Antigenics Inc Composicoes de cpg e adjuvantes de saponina e seus metodos
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
EP1434859A2 (en) * 2001-07-25 2004-07-07 New York University Use of glycosylceramides as adjuvants for vaccines against infections and cancer
CN1909925B (zh) * 2004-02-20 2010-10-13 中国农业大学 一种免疫佐剂
WO2005123120A1 (en) * 2004-06-16 2005-12-29 Smart Drug Systems Inc. Sustained release vaccine composition
RU2288007C2 (ru) * 2005-02-17 2006-11-27 ГНУ ВНИИ ветеринарной вирусологии и микробиологии Способ изготовления ассоциированной инактивированной культуральной вакцины против инфекционного ринотрахеита и парагриппа-3 крупного рогатого скота

Also Published As

Publication number Publication date
CN102186502A (zh) 2011-09-14
ZA201102082B (en) 2011-11-30
TW201010719A (en) 2010-03-16
MX2011001910A (es) 2011-06-20
KR20110044791A (ko) 2011-04-29
JP2012500282A (ja) 2012-01-05
BRPI0917290A8 (pt) 2016-11-01
AR076437A1 (es) 2011-06-15
CN102186502B (zh) 2014-07-16
CA2734654A1 (en) 2010-02-25
KR101320141B1 (ko) 2013-11-13
CO6341568A2 (es) 2011-11-21
HK1157182A1 (en) 2012-06-29
RU2011105863A (ru) 2012-09-27
EP2331126A1 (en) 2011-06-15
AU2009282581A1 (en) 2010-02-25
CA2734654C (en) 2015-02-10
UA101385C2 (ru) 2013-03-25
RU2506094C2 (ru) 2014-02-10
WO2010022135A1 (en) 2010-02-25
US20100047279A1 (en) 2010-02-25
AU2009282581B2 (en) 2013-12-19

Similar Documents

Publication Publication Date Title
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
SMT201600307B (it) Composizione liposomiale
DK2634231T3 (da) Sammensætninger
BRPI0914745A2 (pt) composição nutricional
DE602008002756D1 (de) Bauzusammensetzung
EP2381760A4 (en) CORN PROTEIN COMPOSITION
BRPI1013588A2 (pt) composição
BRPI0917231A2 (pt) composição
BRPI1015474A2 (pt) composição
DK3078664T3 (da) Antiparasitiske dihydroazol-sammensætninger
EP2488022A4 (en) Compositions
BRPI1010709A2 (pt) composição nutricional
BRPI0907376A2 (pt) Fotobiorretador
HUE031343T2 (hu) Immunitásindukáló ágens
BRPI1010301A2 (pt) composição.
IT1392101B1 (it) Composizione comprendente isoflavoni
DK2373293T3 (da) Sammensætninger med reduceret dimerdannelse
UY33161A (es) Composiciones plaguicidas
BRPI1010690A2 (pt) composições
BRPI0907522A2 (pt) biarlamidas
BRPI1005318A2 (pt) composição
EP2479211A4 (en) FLUOR RUBBER COMPOSITION
FR2947556B1 (fr) Composition polyamide modifiee
EP2357204A4 (en) COMPOSITION

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B25A Requested transfer of rights approved

Owner name: PAH W LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS W LLC (US)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.